The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Feasibility and yield of offering genetic counseling to all patients with newly diagnosed high-grade epithelial ovarian cancer.
A. G. Arnold
No relevant relationships to disclose
J. Bhatia
No relevant relationships to disclose
M. F. Phillips
No relevant relationships to disclose
G. J. Gardner
No relevant relationships to disclose
K. M. Bell-McGuinn
No relevant relationships to disclose
C. Aghajanian
No relevant relationships to disclose
R. R. Barakat
No relevant relationships to disclose
K. Offit
No relevant relationships to disclose
N. D. Kauff
Consultant or Advisory Role - Pfizer
Expert Testimony - Pfizer